Orion OYJ (OTCMKTS:ORINY) Shares Gap Down – Here’s What Happened

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) shares gapped down before the market opened on Friday . The stock had previously closed at $41.04, but opened at $39.00. Orion OYJ shares last traded at $39.00, with a volume of 150 shares changing hands.

Orion OYJ Stock Down 5.0%

The company has a market capitalization of $11.01 billion, a price-to-earnings ratio of 17.89 and a beta of 0.06. The business’s 50-day moving average is $37.99 and its 200-day moving average is $37.99. The company has a quick ratio of 1.13, a current ratio of 1.77 and a debt-to-equity ratio of 0.10.

Orion OYJ (OTCMKTS:ORINY) last posted its earnings results on Thursday, April 23rd. The company reported $0.37 earnings per share (EPS) for the quarter. The company had revenue of $488.80 million during the quarter. Orion OYJ had a net margin of 27.14% and a return on equity of 49.17%.

Orion OYJ Company Profile

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.